COVID-19

For more information on COVID-19 and the visitor restrictions in place at Capital Health, click here.
For a message from our President and Chairman of the Board, click here.

Pancreas and Biliary Disorders Program

Click here to view a printable PDF of our Pancreas Cancer Screening Program brochure.

Click here to view a printable PDF of our Capital Health Surgical Group - Dr. Cataldo Doria brochure.

Participating Providers

Jason N. Rogart, MD, FASGE, Director, Interventional Gastroenterology & Therapeutic Endoscopy
Cataldo Doria, MD, PhD, MBA, FACS, Medical Director, Capital Health Cancer Center (Hepato-pancreato-biliary Surgery)
Steven A. Johnson, MD, FACS (General Surgery)

Program Description
Pancreatic and biliary disorders can be among the most challenging gastrointestinal conditions to diagnose and treat, and they are becoming more and more common. The good news is that using advanced diagnostic and therapeutic technologies and techniques, some of these conditions can be prevented and cured, while others can be successfully managed. The Program in Pancreas and Biliary Disorders at Capital Health offers a multidisciplinary approach to optimize not only the care patients will receive, but also to better coordinate their care with referring physicians, medical oncologists, and other providers.

Our expert physicians have dedicated extra years to specialized training in these techniques and technologies, including advanced therapeutic gastrointestinal endoscopy and minimally invasive surgery.

Diseases/conditions treated include (but are not limited to):

  • Benign and malignant tumors of the adrenal glands
  • Cancer of the Ampulla of Vater
  • Bile duct cancer (cholangiocarcinoma)
  • Bile duct strictures
  • Bile duct stones
  • Bile leaks
  • Cholangitis
  • Duodenal cancer
  • Foregut neuroendocrine tumors
  • Gallbladder cancer
  • Gallbladder stones
  • Klatskin's tumor
  • Pancreatic cancer
  • Pancreatic cysts
  • Pancreatic neuroendocrine (islet cell) tumors
  • Abdominal/back pain caused by pancreas or bile duct cancer
  • Pancreatitis (acute and chronic)
  • Autoimmune pancreatitis
  • Pancreatic pseudocyst
  • Pancreatic stones

State-of-the-art endoscopic technology and treatments:

Advanced minimally invasive, robotic-assisted surgical procedures:

  • Adrenalectomy
  • Distal pancreatectomy with and without splenectomy
  • Intra-operative tumor ablation
  • Splenectomy
  • Surgical management of portal hypertension
  • Total pancreatectomy with and without splenectomy
  • Whipple and mini-Whipple (pancreaticoduodenectomy)

Clinical Research and Education
As part of the Center’s mission to improve patient care and remain on the cutting edge of technology, our physicians are continually involved in clinical research and education. All procedures, however, are performed only by the attending interventional gastroenterologist or surgeon, without trainee involvement. Our interventional gastroenterologist, Dr. Jason Rogart, and hepato-pancreato-biliary surgeon, Dr. Cataldo Doria, are often among the first to trial new equipment before or right after it becomes commercially available, and they have published numerous studies in the most prestigious medical journals in gastroenterology and surgery, as well as published numerous book chapters.

Selected Publications

Dr. Jason Rogart
Rogart JN, Loren DE, Signu BS, Kowalski TE. Cyst Wall Puncture and Aspiration during EUS-guided Fine Needle Aspiration May Increase the Diagnostic Yield of Mucinous Cysts of the Pancreas.  Journal of Clinical Gastroenterology2011 Feb;45(2):164-9.
Rogart JN. The Plastic Biliary Stent: An Obsolete Device for Managing Pancreatic Cancer?  (editorial) Journal of Clinical Gastroenterology2010 Jul;44(6):389-90.
Rogart JN, Israel G, Jamidar P. Cystic duct stumpyemamanaged endoscopically. Clinical Gastroenterology &Hepatology2009 Aug;7(8):e43-4.
Rogart JN and Aslanian HR. Massive hemobilia after transjugular liver biopsy treated endoscopically and angiographically. Clinical Gastroenterology &Hepatology2008;6(12):A30.
Rogart JN, Boghos A, Rossi F, Al-Hashem H, Siddiqui UD, Jamidar P, Aslanian H. Analysis of endoscopic management of occluded metal biliary stents at a single tertiary care center. Gastrointestinal Endoscopy2008;68(4):676-682.
Rogart JN and Loren DE. Balloon Sphincteroplasty and Post-Sphincterotomy Balloon Dilation. In: Monkemuller K, Miguel Muñoz-Navas, Mel Wilcox and Todd Baron, eds. Interventional Therapeutic Endoscopy (Karger Publishing, Basel, Switzerland, 2010)
Loren, DE, Kavanaugh B, Kowalski TE, Etemad B, and Rogart JN. Section X: Pancreas and Biliary Diseases. In: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Review and Assessment, 9th ed. DiMarino AJ, ed. (Saunders, 2010)
Niedenthal A, Dancygier H, Rogart J. EndoscopicUltrasonography (chapter 42). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Rogart J, Stenscheke F.Cholangioscopy (chapter 41). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Stenschke F, Dancygier H, Rogart J.  Endoscopic Retrograde and Percutaneous Transhepatic Cholangiography (chapter 40). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Dancygier H, Rogart J.  Evaluation of the patient with hepatobiliary disease: History (chapter 31). In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Dancygier H, Rogart J.  Approach to the Patient with Cholestasis and Jaundice(chapter 52).In: Dancygier H, ed. Clinical Hepatology: principles and practice of hepatobiliary diseases (Springer, 2010).
Lee DS, Kwok K, Gannon C, and Rogart J.Busulfan-associated asymptomatic type I Mirizzi’s Syndrome.  American Journal of Gastroenterology 2010;105(S1):AB543;  Presentation at ACG Annual Meeting 2010, San Antonio.
Rogart JN, Orfanidis N, Korenblit J, Coben R, Infantolino A, Kowalski TE, loren DE. Incremental diagnostic yield of on-site quick-prep smear versus cell-block cytology in EUS-FNA of solid and cystic masses.American Journal of Gastroenterology 2009;104(S3):AB152;  Presentation at ACG Annual Meeting 2009, San Diego.